The laboratory of Dr. Meng Zhang at Emory University School of Medicine and Winship Cancer Institute is looking for a postdoctoral scholar to join our team. The Zhang lab focuses on studying the alterations of RNA transcription, processing, and translation in tumor cells, with the dual goals of both understanding the biology of cancer progression and therapy resistance and identifying potential therapeutic targets to overcome resistance. The lab will integrate a variety of research approaches, including clinical genomics, CRISPR-based functional genomics, and molecular biology, to systematically investigate RNA biology in cancer initiation, progression, and resistance, leading to the discovery of novel therapeutic strategies for patients. The ongoing research directions of the Zhang lab include: 1) Investigation of microproteins' (previously understudied small proteins encoded through non-canonical translation) role and regulation in aggressive prostate cancer; 2) Deciphering the epigenetic mechanisms of oncogenic gene upregulation driven by non-canonical promoters; 3) Discovery of novel druggable regulators of neuroendocrine surface protein target DLL3. If you are an aspiring academic scientist looking to expand your skills and knowledge base in translational cancer research and to boost your scientific career, joining our team could be the perfect opportunity! Opportunities for career growth and authorship should be expected within our lab. You will have the chance to work directly with Dr. Zhang, receive mentorship and training in both research techniques and professional development, lead independent projects, and engage in multidisciplinary collaborations. In addition, you will be encouraged to learn the widely desirable bioinformatics skills under the guidance of Dr. Zhang. We have received generous start-up funds and value a collaborative and supportive lab culture.